Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

ELDNELDN
Showing 8 of 22 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in ELEDON PHARMACEUTICALS INC

GEODE CAPITAL MANAGEMENT, LLC holds 2M shares of ELDN (ELEDON PHARMACEUTICALS INC), worth $7.7M as of 2026-Q2. The position was increased (+9.2% shares). ELDN represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$7.7M

Current Shares

2M

Total Value Change

+$6.8M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2M
+9.2%
$7.7M0.0%$3.94
30
2026-Q1
Increased
1.8M
+26.0%
$5.5M0.0%$2.50
33
2025-Q4
Increased
1.4M
+3.9%
$2.1M0.0%$1.51
27
2025-Q3
Decreased
1.4M
-1.1%
$3.5M0.0%$2.54
0
2025-Q2
Increased
1.4M
+107.6%
$3.8M0.0%$2.69
43
2025-Q1
Increased
666,717
+0.6%
$2.3M0.0%$3.35
26
2024-Q4
Increased
663,101
+75.4%
$2.7M0.0%$4.14
40
2024-Q3
Increased
378,058
+9.7%
$941,5170.0%$2.49
27

Other major holders of ELDN: BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used